Ferreira Ana M, Tuominen Iina, van Dijk-Bos Krista, Sanjabi Bahram, van der Sluis Tineke, van der Zee Ate G, Hollema Harry, Zazula Monika, Sijmons Rolf H, Aaltonen Lauri A, Westers Helga, Hofstra Robert M W
Department of Genetics, University Medical Center Groningen, University of Groningen, Groningen, 9700, RB, The Netherlands.
Hum Mutat. 2014 Dec;35(12):1442-5. doi: 10.1002/humu.22686.
Ribosomal Protein L22 (RPL22) encodes a protein that is a component of the 60S subunit of the ribosome. Variants in this gene have recently been linked to cancer development. Mutations in an A8 repeat in exon 2 were found in a recent study in 52% of microsatellite-unstable endometrial tumors. These tumors are particularly prone to mutations in repeats due to mismatch repair deficiency. We screened this coding repeat in our collection of microsatellite-unstable endometrial tumors (EC) and colorectal tumors (CRC). We found 50% mutation frequency for EC and 77% mutation frequency for CRC. These results confirm the previous study on the involvement of RPL22 in EC and, more importantly, reports for the first time such high mutation frequency in this gene in colorectal cancer. Furthermore, considering the high mutation frequency found, our data point toward an important role for RPL22 in microsatellite instability carcinogenesis.
核糖体蛋白L22(RPL22)编码一种蛋白质,该蛋白质是核糖体60S亚基的组成部分。最近发现该基因的变异与癌症发展有关。在最近的一项研究中,52%的微卫星不稳定子宫内膜肿瘤中发现了外显子2中A8重复序列的突变。由于错配修复缺陷,这些肿瘤特别容易在重复序列中发生突变。我们在我们收集的微卫星不稳定子宫内膜肿瘤(EC)和结直肠肿瘤(CRC)中筛选了这个编码重复序列。我们发现EC的突变频率为50%,CRC的突变频率为77%。这些结果证实了之前关于RPL22参与EC的研究,更重要的是,首次报道了该基因在结直肠癌中的如此高的突变频率。此外,考虑到发现的高突变频率,我们的数据表明RPL22在微卫星不稳定性致癌过程中起着重要作用。